Sarah M. DeSnyder, M.D. FACS, FSSO (Gainer)

Peer-Reviewed Articles

1. So A, Yi M, Simons JM, Kuerer HM, Caudle A, DeSnyder SM, Bedrosian I, Nead KT, Chavez-MacGregor M, Teshome M, Hunt KK. Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol 32(2):922-930, 2025. e-Pub 2025. PMID: 39441324.
2. Sun SX, Duan Z, Kuerer HM, DeSnyder SM, Cunningham C, Zhao H, Giordano SH. Predictors of Emergency Room Visits After Ambulatory Breast Cancer Surgery in the Medicare Population. Ann Surg Oncol 30(3):1689-1698, 2023. e-Pub 2023. PMID: 36402898.
3. Smith-Graziani DJ, Parker PA, Peterson SK, Bedrosian I, Shen Y, Black DM, DeSnyder SM, Hunt KK, Dong W, Brewster AM. Prospective Study of Pain Outcomes Associated With Breast Surgery in Women With Nonhereditary Breast Cancer. Ann Surg 277(3):e617-e623, 2023. e-Pub 2023. PMID: 33938495.
4. Kim, DD, DeSnyder, SM, Dougherty, PM, Cata, JP. Effect of neoadjuvant chemotherapy on intraoperative core temperature in patients with breast cancer. BJA Open 5:100119, 2022. e-Pub 2022. PMID: 37587989.
5. Kuerer HM, Smith BD, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Rauch GM, Trials Group ERC. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial. Lancet Oncol 23(12):1517-1524, 2022. e-Pub 2022. PMID: 36306810.
6. Farley, CR, Irwin, S, Adesoye, T, Sun, SX, DeSnyder, SM, Lucci, A, Shaitelman, SF, Chang, EI, Ueno, NT, Woodward, W, Teshome, M. ASO Visual Abstract. Annals of surgical oncology 29(10):6379-6380, 2022. e-Pub 2022. PMID: 36030283.
7. Hanson SE, Lei X, Roubaud MS, DeSnyder SM, Caudle AS, Shaitelman SF, Hoffman KE, Smith GL, Jagsi R, Peterson SK, Smith BD. Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction. JAMA Surg 157(6):e220631, 2022. e-Pub 2022. PMID: 35416926.
8. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol 28(13):8610-8621. e-Pub 2021. PMID: 34125346.
9. DeSnyder, SM, Yi, M, Boccardo, F, Feldman, S, Klimberg, S, Smith, ML, Thiruchelvam, P, McLaughlin, S. American Society of Breast Surgeons’ Practice Patterns for Patients at Risk and Affected by Breast Cancer-Related Lymphedema. Annals of surgical oncology 28(10):5742-5751, 2021. e-Pub 2021. PMID: 34333706.
10. Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, Ueno NT, Hunt KK, Lucci A, Teshome M. Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol 28(10):5626-5634. e-Pub 2021. PMID: 34292426.
11. Postlewait LM, Partain N, Teshome M, Song J, Meas S, DeSnyder SM, Lim B, Woodward W, Ueno N, Kuerer HM, Rosso K, Hall C, Valero V, Lucci A. The Role of Mastectomy in de novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol 28(8):4265-4274, 2021. e-Pub 2021. PMID: 33403525.
12. Singh P, Scoggins ME, Sahin AA, Hwang RF, Kuerer HM, Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KK. Effectiveness and Safety of Magseed-localization of Excision of Breast Lesions: A Prospective, Phase IV Trial. Ann of Surg Open 1(2):e008, 2020. e-Pub 2020. PMID: 34017965.
13. Postlewait LM, Teshome M, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Woodward WA, Ueno NT, Lucci A. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?. Ann Surg Oncol 27(12):4603-4612, 2020. e-Pub 2020. PMID: 32710271.
14. Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. e-Pub 2020. PMID: 32675511.
15. Ridner SH, Shah C, Boyages J, Koelmeyer L, Ajkay N, DeSnyder SM, McLaughlin SA, Dietrich MS. L-Dex, Arm Volume, and Symptom Trajectories 24 months after Breast Cancer Surgery. Cancer Med 9(14):5164-5173, 2020. e-Pub 2020. PMID: 32483861.
16. Kuritzky A, Reyna C, McGuire KP, Sun W, DeSnyder SM, Aubry S, Nayyar A, Strassle P, Hunt KK, Zhou JM, Lee MC. Evaluation of 2014 Margin Guidelines on Re-Excision and Recurrence rates after Breast-Conserving Surgery: A Multi-Institution Retrospective Study. Breast 51:29-33, 2020. e-Pub 2020. PMID: 32199230.
17. Mericli AF, McHugh T, Kruse B, DeSnyder SM, Rebello E, Offodile AC. Time-Driven Activity-Based Costing to Model Cost Utility of Enhanced Recovery after Surgery Pathways in Microvascular Breast Reconstruction. J Am Coll Surg 230(5):784-794.e3, 2020. e-Pub 2020. PMID: 32224032.
18. Smith BD, Lei X, Diao K, Xu Y, Shen Y, Smith GL, Giordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Swanick CW. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors. Ann Surg Oncol 27(4):1013-1022, 2020. e-Pub 2020. PMID: 31916092.
19. Park KU, Kyrish K, Yi M, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, DeSnyder SM. Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use. Ann Surg Oncol. e-Pub 2019. PMID: 31820211.
20. Stecklein SR, Rosso KJ, Nuanjing J, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Teshome M, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA. Excellent Locoregional control in inflammatory breast Cancer with a personalized radiotherapy approach. Pract Radiat Oncol 9(6):402-409, 2019. e-Pub 2019. PMID: 31132433.
21. Kwon S, Janssen CF, Velasquez FC, Zhang S, Aldrich MB, Shaitelman SF, DeSnyder SM, Sevick-Muraca EM. Radiation Dose-Dependent Changes in Lymphatic Remodeling. Int J Radiat Oncol Biol Phys 105(4):852-860, 2019. e-Pub 2019. PMID: 31394167.
22. Ridner SH, Dietrich MS, Cowher MS, Taback B, McLaughlin S, Ajkay N, Boyages J, Koelmeyer L, DeSnyder SM, Wagner J, Abramson V, Moore A, Shah C. A Randomized Trial Evaluating Bioimpedance Spectroscopy versus Tape Measurement for the Prevention of Lymphedema following Locoregional Treatment for Breast Cancer: Interim Analysis. Ann Surg Oncol 26(10):3250-3259, 2019. e-Pub 2019. PMID: 31054038.
23. Litton JK, Scoggins ME, Hess KR, Adrada BE, Murthy RK, Damodaran S, DeSnyder SM, Brewster AM, Barcenas CH, Valero V, Whitman GJ, Schwartz-Gomez J, Mittendorf EA, Thompson AM, Helgason T, Ibrahim N, Piwnica-Worms H, Moulder SL, Arun BK. Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol:JCO1901304. e-Pub 2019. PMID: 31461380.
24. DeSnyder SM, Kheirkhah P, Travis ML, Lilly SE, Bedrosian I, Buchholz TA, Schaverien MV, Shaitelman SF. Optimizing Patient Positioning to Reduce Variation in the Measurement of Breast Cancer-Related Lymphedema. Lymphat Res Biol 17(4):440-446, 2019. e-Pub 2019. PMID: 30562149.
25. Park KU, Kyrish K, Terrell J, Yi M, Caudle AS, Hunt KK, Kuerer HM, Bedrosian I, Thompson A, DeSnyder SM. Surgeon Perception Versus Reality: Opioid Use After Breast Cancer Surgery. J Surg Oncol, 2019. e-Pub 2019. PMID: 30737785.
26. Coroneos CJ, Wong FC, DeSnyder SM, Shaitelman SF, Schaverien MV. Correlation of L-Dex Bioimpedance Spectroscopy with Limb Volume and Lymphatic Function in Lymphedema. Lymphat Res Biol 17(3):301-307, 2019. e-Pub 2019. PMID: 30388062.
27. Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle AS, DeSnyder SM, Fitzsullivan E, Hunt KK, Kuerer HM, Lucci A, Meric-Bernstam F, Mittendorf EA, Park K, Teshome M, Thompson AM, Hwang RF. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients. Ann Surg Oncol 26(3):815-820, 2019. e-Pub 2019. PMID: 30556120.
28. Caudle AS, Kuerer HM, Krishnamurthy S, Shin K, Hobbs BP, Ma J, Mittendorf EA, Washington AC, DeSnyder SM, Black DM, Hunt KK, Yang WT. Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study. Cancer 125(3):365-373, 2019. e-Pub 2019. PMID: 30359480.
29. Tadros AB, Smith BD, Shen Y, Lin H, Krishnamurthy S, Lucci A, Barcenas CH, Hwang RF, Rauch G, Santiago L, Strom EA, DeSnyder SM, Yang WT, Black DM, Albarracin CT, Chavez-MacGregor M, Hunt KK, Kuerer HM. Ductal Carcinoma In Situ and Margins <2mm: Contemporary Outcomes With Breast Conservation. Ann Surg 269(1):150-157, 2019. e-Pub 2019. PMID: 28742682.
30. Tevis SE, Neuman HB, Mittendorf EA, Kuerer HM, Bedrosian I, DeSnyder SM, Thompson AM, Black DM, Scoggins ME, Sahin AA, Hunt KK, Caudle AS. Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins. Ann Surg Oncol 25(10):2932-2938, 2018. e-Pub 2018. PMID: 29947001.
31. Ridner SH, Dietrich MS, Spotanski K, Doersam JK, Cowher MS, Taback B, McLaughlin S, Ajkay N, Boyages J, Koelmeyer L, DeSnyder SM, Shah C, Vicini F. A Prospective Study of L-Dex Values in Breast Cancer Patients Pretreatment and Through 12 Months Postoperatively. Lymphat Res Biol 16(5):435-441, 2018. e-Pub 2018. PMID: 30130147.
32. DeSnyder SM, Hunt KK, Dong W, Smith BD, Moran MS, Chavez-MacGregor M, Shen Y, Kuerer HM, Lucci A. American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation. Ann Surg Oncol 25(10):2965-2974, 2018. e-Pub 2018. PMID: 29987598.
33. Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, Nelson JC, DeSnyder SM, Cook RL, Hunt KK, Volk RJ, Cantor SB, Dong W, Brewster AM. Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer. J Clin Oncol 36(25):2630-2638, 2018. e-Pub 2018. PMID: 30044695.
34. Matsuda N, Wang X, Lim B, Krishnamurthy S, Alvarez RH, Willey JS, Parker CA, Song J, Shen Y, Hu J, Wu W, Li N, Babiera GV, Murray JL, Arun BK, Brewster AM, Reuben JM, Stauder MC, Barnett CM, Woodward WA, Le-Petross HTC, Lucci A, DeSnyder SM, Tripathy D, Valero V, Ueno NT. Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer. JAMA Oncol 4(9):1207-1213, 2018. e-Pub 2018. PMID: 29879283.
35. Weiss A, Mittendorf EA, DeSnyder SM, Hwang RF, Bea V, Bedrosian I, Hoffman K, Adrade B, Sahin AA, Kuerer HM, Hunt KK, Caudle AS. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice. Clin Breast Cancer 18(4):276-281, 2018. e-Pub 2018. PMID: 29100726.
36. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg 267(5):946-951, 2018. e-Pub 2018. PMID: 28549010.
37. DeSnyder SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, Whitman GJ, Ueno NT, Woodward WA, Kuerer HM, Akay CL, Babiera GV, Yang W, Lucci A. Prospective feasibility trial of sentinel lymph node biopsy in the setting of inflammatory breast cancer. Clin Breast Cancer 18(1):e73-e77, 2018. e-Pub 2018. PMID: 28755879.
38. Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer 9(8):1437-1447, 2018. e-Pub 2018. PMID: 29721054.
39. Marta GN, Poortmans P, de Barros AC, Filassi JR, Freitas Junior R, Audisio RA, Mano MS, Meterissian S, DeSnyder SM, Buchholz TA, Hijal T. Multidisciplinary International Survey of Post-Operative Radiation Therapy Practices after Nipple-Sparing or Skin-Sparing Mastectomy. Eur J Surg Oncol 43(11):2036-2043, 2017. e-Pub 2017. PMID: 28967564.
40. Rosso KJ, Tadros AB, Weiss A, Werneckie C, DeSnyder SM Kuerer HM, Ueno N, Stecklein S, Woodward WA, Lucci A. Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery. Ann Surg Oncol 24(10):2981-2988, 2017. e-Pub 2017. PMID: 28766220.
41. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. A Ten-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction. Ann Surg Oncol 24(10):2965-2971, 2017. e-Pub 2017. PMID: 28766219.
42. Fayanju OM, Hall CS, Bauldry JB, Karhade M, Valad LM, Kuerer HM, DeSnyder SM, Barcenas CH, Lucci A. Body Mass Index Mediates the Prognostic Significance of Circulating Tumor Cells in Inflammatory Breast Cancer. Am J Surg 214(4):666-671, 2017. e-Pub 2017. PMID: 28720217.
43. McLaughlin SA, Staley AC, Vicini F, Thiruchelvam P, Hutchison NA, Mendez J, MacNeill F, Rockson SG, DeSnyder SM, Klimberg S, Alatriste M, Boccardo F, Smith ML, Feldman SM. Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions. Ann Surg Oncol 24(10):2818-2826, 2017. e-Pub 2017. PMID: 28766232.
44. Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EA. Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members. Ann Surg Oncol 224(10):2925-2934. e-Pub 2017. PMID: 28766207.
45. Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A, Caudle AS, DeSnyder SM, Teshome M, Barcenas C, Miggins M, Adrada BE, Moseley T, Hwang RF, Hunt KK, Kuerer HM. Identification of Patients with Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surgery 152(7):665-670, 2017. e-Pub 2017. PMID: 28423171.
46. Harao N, Forget MA, Roszik J, Gao H, Babiera GV, Krishnamurthy S, Chacon JA, Li S, Mittendorf EA, DeSnyder SM, Rockwood KF, Bernatchez C, Ueno NT, Raadvanyi LG, Vence L, Haymaker C, Reuben JM. 4-1BB-enhanced expansion of CD8+ TIL from triple-negative breast cancer unveils mutation-specific CD8+ T cells. Cancer Immunol Res 5(6):439-445, 2017. e-Pub 2017. PMID: 28473315.
47. Carter SA, Lyons GR, Kuerer HM, Bassett RL, Oates S, Thompson A, Caudle AS, Mittendorf EA, Bedrosian I, Lucci A, DeSnyder SM, Babiera G, Yi M, Baumann DP, Clemens MW, Garvey PB, Hunt KK, Hwang RF. Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction. Ann Surg Oncol 23(10):3190-8, 2016. e-Pub 2016. PMID: 27406093.
48. Hall C, Karhade MG, Bowman Bauldry JB, Valad LM, Kuerer HM, DeSnyder SM, Lucci A. Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Non-Metastatic Breast Cancer Patients. J Am Coll Surg 223(1):20-29, 2016. e-Pub 2016. PMID: 27049782.
49. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol 34(10):1072-8, 2016. e-Pub 2016. PMID: 26811528.
50. Hall CS, Karhade M, Laubacher BA, Kuerer HM, Krishnamurthy S, DeSnyder SM, Anderson AE, Valero V, Ueno NT, Li Y, Su X, Lucci A. Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer 107(11), 2015. e-Pub 2015. PMID: 26374427.
51. DeSnyder SM, Hunt KK, Smith BD, Moran MS, Klimberg S, Lucci A. Assessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer. Ann Surg Oncol 22(10):3250-6, 2015. e-Pub 2015. PMID: 26202554.
52. Hall C, Karhade M, Laubacher B, Anderson A, Kuerer HM, DeSnyder SM, Lucci A. Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer. Ann Surg Oncol 22:S552-S558, 2015. e-Pub 2015. PMID: 25968619.
53. MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KE. Therapeutic Radiation Dose Delivered to the Low Axilla During Whole Breast Radiation Therapy in the Prone Position: Implications for Targeting the Undissected Axilla. Pract Radiat Oncol 4(2):116-22, 2014. e-Pub 2014. PMID: 24890352.
54. Fitzsullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HM. Incidence and Consequence of Close Margins in Patients with Ductal Carcinoma in Situ Treated with Mastectomy: Is Further Therapy Warranted? 20(13):4103-12, 2013. e-Pub 2013. PMID: 23975313.
55. Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns. Ann Surg Oncol 19(10):3144-51, 2012. e-Pub 2012. PMID: 22847123.
56. Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. Changing Behavior in Clinical Practice in Response to the ACOSOG Z0011 Trial: A Survey of the American Society of Breast Surgeons. Ann Surg Oncol 19(10):3152-8, 2012. e-Pub 2012. PMID: 22820938.
57. Gainer SM, Lodhi AK, Bhattacharyya A, Krishnamurthy S, Kuerer HM, Lucci A. Invasive Lobular Carcinoma Predicts Micrometastasis in Breast Cancer. J Surg Res 177(1):93-6, 2012. e-Pub 2012. PMID: 22482764.
58. Gainer SM, Patel SJ, Seethamraju H, Moore LW, Knight RJ, Gaber AO. Increased Mortality of Solid Organ Transplant Recipients with H1N1 Infection: A Single Center Experience. Clin Transplant 26(2):229-37, 2012. e-Pub 2012. PMID: 21501229.
59. Gainer SM, Lee E, Lucci A. The Suture Scaffold Technique for Improved Cosmesis in Partial Mastectomy Defects. J Surg Oncol 102(2):184-6, 2010. e-Pub 2010. PMID: 20648592.
60. Tsonis PA, Madhavan M, Call MK, Gainer SM, Rice A, Del Rio-Tsonis K. Effects of a CDK Inhibitor on Lens Regeneration. Wound Repair Regen 12(1):24-9, 2004. e-Pub 2004. PMID: 14974961.

Invited Articles

1. DeSnyder SM, Teo I, Fingeret M. Body Image Struggles and Breast Cancer Care: An Under-Recognized and Undertreated Issue with Important Implications for All Patients. Future Medicine: Breast Cancer Management 3(3):251-260, 2014. e-Pub 2014.
2. Gainer SM, Lucci A. Oncoplastics: Techniques for Reconstruction of Partial Breast Defects Based on Tumor Location. J Surg Oncol 103(4):341-7, 2011. e-Pub 2011. PMID: 21337569.

Manuals, Teaching Aids, Other Teaching Publications

1. DeSnyder SM. Lymphedema/Lymphangitis Module. Surgical Council of Resident Education (SCORE), 2019.
2. DeSnyder SM. Improving Preoperative Counseling for At-Risk Patients with Melanona. Patient Education Video, 2016.
3. DeSnyder SM. Improving Pre-Operative Lymphedema Counseling for At-Risk Patients. Patient Education Video, 2015.
4. Fingeret MC, Nipomnick S, Peterson E, Bradford A, Crosby M, Dow A, Gonzales-Phillips D, Gainer SM, Smith B, Wagner J. Coping with Appearance Changes Due to Breast Cancer. Patient Education Manual, 2012.
5. Gainer SM, Zampieri JB, Santora SJ, Bass BL. Breast Cancer: A Guide to Diagnosis, Treatment, and Recovery. Patient Decision Support Video, 2011.
6. Gainer SM, Zampieri JB, Santora SJ, Bass BL. Breast Cancer: A Guide to Diagnosis, Treatment, and Recovery. Patient Decision Support Manual, 2011.

Other Articles

1. Piotrowski MJ, Yi M, Le-Petross C, Teshome M, Kuerer HM, Lee J, Hunt KK, DeSnyder SM Optimization of intraoperative lumpectomy specimen labeling. Surg Oncol. Insight 1(1), 2024.
2. Cobb, AN, DeSnyder, SM Risk Factors for Breast Cancer-Related Lymphedema, Risk Reduction, and Myths about Precautionary Behaviors. Current Breast Cancer Reports 15(1):1-11, 2023.
3. Ludwig K, Wexelman B, Chen S, Cheng G, DeSnyder S, Golesorkhi N, Greenup R, James T, Lee B, Pockaj B, Vuong B, Fluharty S, Fuentes E, Rao R, Quality Committee ASOBSPS Home Recovery After Mastectomy: Review of Literature and Strategies for Implementation American Society of Breast Surgeons Working Group. Ann Surg Oncol 29(9):5799-5808, 2022. PMID: 35503389.
4. Prinsloo S, Rebello E, Cata JP, Black D, DeSnyder SM, Cohen L Electroencephalographic Correlates of Hypnosedation during Breast Cancer Surgery. Breast J 25(4):786-787, 2019. PMID: 31127667.
5. Reyna C, DeSnyder SM Intraoperative Margin Assessment in Breast Cancer Management. Surg Oncol Clin N Am 27(1):155-165, 2018. PMID: 29132558.
6. Shaitelman SF, Chiang YJ, Griffin KD, DeSnyder SM, Smith BD, Schaverien MV, Woodward WA, Cormier JN Radiation Therapy Targets and the Risk of Breast Cancer-Related Lymphedema: A Systematic Review and Network Meta-Analysis. Breast Cancer Res Treat 162(2):201-215, 2017. PMID: 28012086.

Editorials

1. DeSnyder SM. Invited Editorial: Identifying Factors Predicting Long-Term Opioid Use After Mastectomy. Ann Surg Oncol 27(4):969-970, 2020. PMID: 32026065.
2. DeSnyder SM, Hanasono MM. Invited Editorial: Enhanced Recovery Minimizes Opioid Use and Length of Stay in Patients Undergoing Mastectomy with Reconstruction. Ann Surg Oncol 26(11):3418-3419, 2019. PMID: 31407183.
3. Marta GN, Poortmans P, de Barros AC, Filassi JR, Freitas-Junior R, Audisio RA, Mano MS, Meterissian S, DeSnyder SM, Buchholz TA, Hijal T. Reply to: Mastectomy skin flap thickness. Eur J Surg Oncol 44(7):1119-1120, 2018. PMID: 29739639.
4. Fouad TM, Barrera AMG, Reuben JM, Lucci A, Woodward WA, Stauder MC, Lim B, DeSnyder SM, Arun B, Gildy B, Valero V, Hortobagyi GN, Ueno NT. Inflammatory Breast Cancer: A Proposed Conceptual Shift in the UICC–AJCC TNM Staging System. Lancet Oncol 18(4):e228–e232, 2017. PMID: 28368261.
5. DeSnyder SM, Schaverien MV. Commentary on: Basta MN, Fox JP, Kanchwala SK, et al. Complicated Breast Cancer-Related Lymphedema: Evaluating Health Care Resource Utilization and Associated Cost of Management [The American Journal of Surgery 211(1):133-141,2016]. Breast Diseases: A Year Book Quarterly 27(3), 2016.
6. Gainer SM, Mittendorf EA. Commentary on: Sweeting RS, Klauber-Demore N, Meyers MO, et al. Young Women with Locally Advanced Breast Cancer Who Achieve Breast Conservation after Neoadjuvant Chemotherapy have a Low Local Recurrence Rate [American Surgeon 77(7):850-85, 2011]. Breast Diseases: A Year Book Quarterly 21(1):100-101, 2012.
7. Gainer SM, Mittendorf EA. Commentary on: Saxena N, Harman M, Aziz R, et al. Prognostic Value of Axillary Lymph Node Status after Neoadjuvant Chemotherapy. Results from a Multicentre Study [Eur J Cancer 47(8):1186-1192, 2011]. Breast Diseases: A Year Book Quarterly 22(4):382, 2012.
8. Gainer SM, Babiera GV. Commentary on:Hazard HW, Gorla SR, Scholtens D, et al. Surgical Resection of the Primary Tumor, Chest Wall Control, and Survival in Women with Metastatic Breast Cancer [Cancer 113(8):2011-2019, 2008]. Breast Diseases: A Year Book Quarterly 20(3):295-296, 2009.

Abstracts

1. Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt K, Kuerer H, Singh P, Sun S, Tamirisa N, Teshome M, Hwang RF. To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?. Ann Surg Oncol 30(13):8327-8334, 2023. e-Pub 2023. PMID: 37670121.
2. Yoder AK, Xu T, Youssef P, DeSnyder S, Marqueen KE, Isales L, Lin R, Smith BD, Woodward WA, Stauder MC, Strom EA, Aldrich MB, Shaitelman SF. Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast Cancer. Pract Radiat Oncol. e-Pub 2023. PMID: 37914083.
3. Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SF. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast 68:205-215, 2023. e-Pub 2023. PMID: 36863241.
4. Farley CR, Irwin S, Adesoye T, Sun SX, DeSnyder SM, Lucci A, Shaitelman SF, Chang EI, Ueno NT, Woodward WA, Teshome M. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Ann Surg Oncol 29(10):6370-6378, 2022. e-Pub 2022. PMID: 35854031.
5. Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith BD, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat 195(1):33-41, 2022. e-Pub 2022. PMID: 35816269.
6. Farley C, DeSnyder SM, Teshome M. Incidence of lymphedema in inflammatory breast cancer patients following trimodality treatment, 2022. e-Pub 2022.
7. Shaitelman SF, Sevick-Muraca EM, Chan W, et al. Dermal backflow, detected by near-infrared fluorescence lymphatic imaging, is a very accurate early prognostic of breast cancer-related lymphedema development. Presented at the 10th International Lymhoedema Framework Conference, 2021. e-Pub 2021.
8. DeSnyder SM, Yi M, Boccardo F, Feldman S, Klimberg S, Smith M, Thiruchelvam PTR, McLaughlin S. American Society of Breast Surgeons Practice Patterns for Patients At-risk and Affected by Breast Cancer-Related Lymphedema. 22nd Annual Meeting of the American Society of Breast Surgeons, 2021. e-Pub 2021.
9. Garner DC, DeSnyder SM, Isales LE, Woodward W, Strom EA, Smith B, Stauder MC, Aldrich MB, Shaitelman SF. Emerging role of inflammatory markers in early onset breast cancer-related lymphedema. Fletcher Society Conference, 2021. e-Pub 2021.
10. Adesoye T, Babyemi T, Postlewait L, Cox S, DeSnyder SM, Sun S, Hunt KK, Lucci A, Teshome M. Inflammatory Breast Cancer At Extremes of Age. 22nd Annual Meeting of the American Society of Breast Surgeons, 2021. e-Pub 2021.
11. Yi M, Chavez-MacGregor M, Smith BD, Caudle AS, DeSnyder SM, Kuerer HM, Hunt KK. Comparing Survival Differences Between Patients Undergoing Breast-Conserving Therapy vs. Total Mastectomy as a First Treatment for Early-Stage Breast Cancer, 2020. e-Pub 2020.
12. Hanson SE, Lei X, Roubaud M, DeSnyder SM, Caudle AS, Shaitelman S, Hoffman K, Jagsi R, Smith BD. Patient-reported outcomes favor autologous reconstruction over implant-based reconstruction following mastectomy in early stage breast cancer survivors surveyed from the Texas Cancer Registry, 2020. e-Pub 2020.
13. Garner DC, DeSnyder SM, Isales LE, Woodward W, Strom EA, Smith B, Stauder MC, Aldrich MB, Shaitelman SF. Emerging role of inflammatory markers in early onset breast cancer-related lymphedema, 2020. e-Pub 2020.
14. Postlewait LM, Teshome M, Kuerer HM, DeSnyder SM, Woodward W, Lim B, Ueno NT, Lucci A. Factors Associate with pathologic node negativity in inflammatory breast cancer: Are there patients who may be candidates for sentinel lymph node biopsy or targeted axillary dissection. 21st Annual Meeting of the American Society of Breast Surgeons, 2020. e-Pub 2020.
15. Piotrowski MJ, Yi M, Contreras A, Hunt KK, Hwang RF, Kuerer HM, Le-Petross C, Teshome M, Underbrink A, DeSnyder SM. Optimization of Intraoperative Lumpectomy Specimen Labeling, 2020. e-Pub 2020.
16. Rebello E, Black S, DeSnyder S, Cleckler-Hughes K, Engle R, Cohen L. Hypnosedation as an Alternative to General Anesthesia for Breast Cancer Surgery in a Patient with Severe Chronic Obstructive Pulmonary Disease, 2020. e-Pub 2020.
17. Hanson SE, Lei X, DeSnyder SM, Caudle AS, Smith BD. Patient-reported outcomes favor breast conservation over mastectomy with reconstruction in breast cancer survivors surveyed from the Texas Cancer Registry, 2019. e-Pub 2019.
18. Diao K, Swanick CW, Lei X, Xu Y, Shen Y, Smith GL, Ciordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Smith BD. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes after Breast Conserving Therapy in Older Breast Cancer Survivors, 2019. e-Pub 2019.
19. Piotrowski M, Yi M, Bedrosian I, Caudle AS, Contreras A, Hunt KK, Le-Petross C, Miggins M, Teshome M, Underbrink AM, DeSnyder SM. Optimization of Intraoperative Lumpectomy Specimen Labeling, 2019. e-Pub 2019.
20. Nurudeen SM, Yi M, Kuerer HM, Caudle AS, DeSnyder SM, Mittendorf EM, Bedrosian I, Hunt KK. Long-term Survival Following Sentinel Lymph Node Biopsy in Clinically Node Negative Breast Cancer Patients Treated with Primary Surgery or Neoadjuvant Chemotherapy, 2019. e-Pub 2019.
21. Ridner SH, Dietrich MS, Cowher MS, Taback B, McLaughlin S, Ajkay N, Boyages J, Koelmeyer L, DeSnyder SM, Wagner J, Arthur D, Moore A, Vicini F, Shah C. A Randomized Trial Evaluating Bioimpedance Spectroscopy versus Tape Measurement for the Prevention of Lymphedema following Locoregional Treatment for Breast Cancer: Interim Analysis, 2019. e-Pub 2019.
22. Park KU, Kyrish K, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, DeSnyder SM. Opioid Use After Segmental Mastectomy: Identifying Risk Factors for Being in the Highest Quartile of Opioid Use, 2019. e-Pub 2019.
23. Singh P, Scoggins M, Sahin A, Hwang R, Kuerer H, Caudle A, Mittendorf E, Thompson A, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt K. Effectiveness and Safety of Magseed-Localization for Surgical Excision of Breast Lesions, 2019. e-Pub 2019.
24. Kyrish K, Park KU, Yi M, Terrell J, Akay CL, Bedrosian I, Black DM, Caudle AS, Checka CM, Feig BW, Hunt KK, Hwang RF, Kuerer HM, Lucci A, Meric-Bernstam F, Refinetti APC, Reyna C, Ross M, Teshome M, Thompson A, DeSnyder SM. Opioid Use After Breast Surgery: Prescription Patterns Vs Patient Use, 2018. e-Pub 2018.
25. Park KU, Kyrish K, Terrell JA, Akay CL, Bedrosian I, Black D, Caudle AS, Checka C, Feig BW, Hunt KK, Hwang RF, Kuerer HM, Lucci A, Meric-Bernstam F, Refinetti AP, Reyna C, Ross MI, Teshome M, Thompson AM, DeSnyder SM. Opioid Prescriptions After Breast Cancer Surgery: Perception and Reality, 2018. e-Pub 2018.
26. Travis M, Kheirkhah P, DeSnyder SM, Shaitelman SF. Reducing Variation of Metrics for the Diagnosis of Breast Cancer-Related Lymphedema Among Therapists in Multi-Rehab Clinics, 2018. e-Pub 2018.
27. Tevis SE, Neuman HB, Mittendorf EA, Kuerer HM, Bedrosian I, DeSnyder SM, Thompson A, Black DM, Scoggins ME, Sahin AA, Hunt KK, Caudle AS. Multidisciplinary Margin Assessment Reduces Number of Positive Margins, 2018. e-Pub 2018.
28. DeSnyder SM, Hunt KK, Dong W, Smith B, Moran MS, Chavez-MacGregor M, Shen Y, Kuerer HM, Lucci A. American Society of Breast Surgeons Practice Patterns following Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation, 2018. e-Pub 2018.
29. Tevis S, Bedrosian I, Bassett RL, FitzSullivan E, Barcenas CH, Meric-Bernstam F, Hunt KK, Caudle AS, Kuerer HM, Mittendorf EA, Thompson A, Teshome M, Lucci A, DeSnyder SM, Black S, Park KU, Hwang R. Evaluation of OncotypeDX as a Predictor of Nodal Burden in Clinically Node Negative Breast Cancer Patients, 2018. e-Pub 2018.
30. Nurudeen SM, Yi M, Kuerer H, Caudle A, DeSnyder SM, Morrison M, Mittendorf E, Bedrosian I, Hunt K. Factors Associated with Local-Regional Recurrence Following Sentinel Node Dissection (SLND) in Clinically Node Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, 2018. e-Pub 2018.
31. Shaitelman S, Rasmussen JC, DeSnyder SM, Morrison M, Mittendorf EA, Chan W, Sevick-Muraca EM, Aldrich MD. Lymphatic Abnormalitites in Pre-Surgery Breast Cancer Patients as Assessed by Near-Infrared Flourescence Lymphatic Imaging. The Lymphedema Symposium at Harvard Medical School, 2017. e-Pub 2017.
32. Tadros AB, Smith BD, Shen Y, Lin H, Krishnamurthy S, Lucci A, Barcenas CH, Hwang RH, Rauch G, Santiago L, Strom EA, DeSnyder SM, Yang WT, Black DM, Albarracin CT, Mac Gregor MC, Hunt KK, Kuerer HM. Clear margins <2 mm in patients with ductal carcinoma in situ are not a contraindication for breast conservation surgery with radiation therapy, 2017. e-Pub 2017.
33. Hwang R, Jiang J, Carter S, Shih T, Oates S, Butler C, Kuerer H, Babiera G, Mittendorf E, Lucci A, Caudle A, Bedrosian I, Thompson A, DeSnyder SM, Baumann D, Clemens M, Garvey P, Schaverien M, Buchholz T, Giordano S, Hunt K, Smith B. Cost and complication burden of oncoplastic breast conservation compared to other treatment options in women with breast cancer, 2017. e-Pub 2017.
34. Weiss A, Kuerer HM, Yang WT, Krishnamurthy S, DeSnyder SM, Black DM, Babiera GV, Teshome M, Hunt KK, Caudle AS. Potential for Targeted Axillary Dissection in Patients Who Do Not Receive Neoadjuvant Chemotherapy, 2017. e-Pub 2017.
35. Rosso K, Tadros AB, Weiss AC, Woodward W, Ueno N, Kuerer HM, DeSnyder SM, Karhade MG, Bauldry JB, Lucci A. Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery, 2017. e-Pub 2017.
36. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Baumann DP, Garvey PB, Barcenas CH, Kuerer HM. Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction: A ten-year experience with delayed-immediate reconstruction, 2017. e-Pub 2017.
37. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Santiago L, Lucci A, Hobbs BP, Gilcrease M, Hwang R, Candelaria RP, Chavez MacGregor A, Arribas E, Moseley T, Teshome M, Miggins MV, Smith BD, Valero V, Hunt KK, Yang WT. Feasibility trial for identification of patients for eliminating breast cancer surgery following neoadjuvant systemic therapy. Cancer Research 77(4), 2017. e-Pub 2017.
38. Brewster AM, Peterson S, Yu S, Bedrosian I, Thompson A, Black S, Nelson J, Cook R, DeSnyder SM, Hunt K, Volk R, Cantor S, Wenli D, Parker, P. Psychosocial Outcomes of Contralateral Prophylactic Mastectomy, 2017. e-Pub 2017.
39. DeSnyder SM, Mittendorf EA, Babiera G, Whitman G, Yang W, Krishnamurthy S, Ueno N, Le-Petross H, Woodward W, Lucci A. Prospective Study of the Feasibility of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer. Official Proceedings, 18th Annual Meeting of the American Society of Breast Surgeons 24(2):154, 2017. e-Pub 2017.
40. Marta GN, Poortmans P, Riccardo A, Ruffo FJ, Alfredo B, DeSnyder SM, Sarkis M, Buchholz TA, Tarek H. Post-operative Irradiation after Nipple- Sparing or Skin-Sparing Mastectomy: An International Survey In: ESTRO 36 - European Society for Radiatherapy and Oncology. Radiother Oncol(123 Suppl):S636 - S637, 2017. e-Pub 2017.
41. Hwang R, Jiang J, Carter S, Shih T, Oates S, Butler C, Kuerer H, Babiera G, Mittendorf EA, Lucci A, Caudle A, Bedrosian I, Thompson A, DeSnyder SM, Baumann D, Clemens M, Garvey P, Schaverien M, Buchholz T, Giordano S, Hunt K, Smith B. Cost and complication burden of oncoplastic breast conservation compared to other treatment options in women with breast cancer. Official Proceedings, 18th Annual Meeting of the American Society of Breast Surgeons 24(2):24, 2017. e-Pub 2017.
42. Weiss A, Mittendorf EA, DeSnyder SM, Hwang R, Bedrosian I, Hoffman K, Bea V, Sahin AA, Kuerer HM, Hunt KK, Caudle AS. ACOSOG Z0011: Impact After 5 Years. Official Proceedings, 18th Annual Meeting of the American Society of Breast Surgeons 24(2):168, 2017. e-Pub 2017.
43. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, DeSnyder SM, Bedrosian I, Black DM, Teshome M, Hunt KK, Kuerer HM. Factors Impacting the Accuracy of Targeted Axillary Dissection. Annals of Surgical Oncology 24(S10):14, 2017. e-Pub 2017.
44. Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EA. The use of sentinel lymph node dissection after neoadjuvant chemotherapy in clinically node-positive patients: Practice patterns of members of the American Society of Breast Surgeons. Official Proceedings, 18th Annual Meeting of the American Society of Breast Surgeons 24(2):28, 2017. e-Pub 2017.
45. Tadros A, Yang WT, Krishnamurthy S, Rauch G, Smith B, Valero V, Black DM, Caudle AS, Lucci A, DeSnyder SM, Teshome M, Barcenas C, Miggins M, Moseley T, Adrada B, Hwang R, Hunt KK, Kuerer HM. Eliminating axillary surgery in exceptional responders to neoadjuvant chemotherapy with documented pathologic complete response in the breast. Annals of Surgical Oncology 24(Suppl 1), 2017. e-Pub 2017.
46. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. Radiotherapy After Skin-Sparing Mastectomy and Placement of a Tissue Expander: Effectiveness of a Coordinated, Multidisciplinary Approach 98(2):E19, 2017. e-Pub 2017.
47. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Santiago L, Lucci A, Hobbs BP, Gilcrease M, Hwang R, Candelaria RP, Chavez Mac-Gregor M, Arribas E, Moseley T, Teshome M, Miggins MV, Smith BD, Valero V, Hunt KK, Yang WT. Feasibility trial for identification of patients for eliminating breast cancer surgery following neoadjuvant systemic therapy, 2016. e-Pub 2016.
48. Hall C, Valad L, Karhade M, Bauldry J, Kuerer HK, DeSnyder SM, Lucci A. Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Nonmetastatic Breast Cancer Patients 223(1):29-31, 2016. e-Pub 2016.
49. Carter S, Lyons GR, Bassett Jr RL, Babiera G, Bedrosian I, Hunt KK, DeSnyder SM, Kuerer HM, Caudle AS, Black S, Ross MI, Teshome M, Thompson A, Yi M, Oates S, Gravey PB, Baumann DP, Hwang R. An Analysis of 5651 Surgeries for Patients with Breast Cancer: the Emerging Trend for Breast Conservation and Oncoplastic Reconstruction with Oncologic and Post-Operative Outcomes 16:0232, 2016. e-Pub 2016.
50. Matsuda N, Wang X, Krishnamurthy S, Willey JS, Lim B, Parker CA, Babiera G, Booser DJ, Murray III JL, Arun BK, Brewster A, Reuben JM, Stauder MC, Woodward W, Lucci A, DeSnyder SM, Tripathy D, Valero V, Ricardo A. Phase II study of panitumumab, nab-paclitaxel, and carboplatin followed by FEC neoadjuvant chemotherapy for patients with primary HER2-negative inflammatory breast cancer, 2016 ASCO Annual Meeting 34, 2016. e-Pub 2016.
51. Fayanju O, Hall CS, Bauldry J, Karhade M, Valad L, Kuerer HK, DeSnyder SM, Barcenas C, Lucci A. The Impact of Body Mass Index on the Prognostic Power of Circulating Tumor Cells and Pathologic Complete Response following Neoadjuvant Chemotherapy for Breast Cancer 23:71-72, 2016. e-Pub 2016.
52. Kuerer HM, Karhade MG, DeSnyder, SM, Barcenas CH, Hall CS, Valad LM, Bauldry JB. Circulating Tumor Cells After Neoadjuvant Therapy and Relapse in Stage I-III Breast Cancer, 2016. e-Pub 2016.
53. Shaitelman SF, Ferguson SE, DeSnyder SM, Kheirkhah P, Lilly S, Travis M, Johnson T, Alvarez A, Rohe E, Buchholz TA, Bedrosian I. Initiating a lymphedema screening program for breast cancer patients: Determining variability as a first step towards standardization. Journal of Clinical Oncology 34(7 Suppl):264, 2016. e-Pub 2016.
54. Bordes MC, Weston J, Hunt KK, DeSnyder SM, Zhang A, Reece G, Markey M, Merchant F, Fingeret M. Intraoperative 3D Imaging of Mastectomy Specimens to Inform Reconstructive Surgery, 2016. e-Pub 2016.
55. Shaitelman SF, Ferguson SE, DeSnyder SM, Kheirkhah P, Lilly SE, Travis M, Johnson TA, Alvarez A, Rohe DK, Buchholz TA, Bedrosian I. Initiating a lymphedema screening program for breast cancer patients: Determining variability as a first step towards standardization, 2016. e-Pub 2016.
56. Travis M, Shaitelman SF, Kheirkhah P, Buchholz TA, DeSnyder SM, Chang EI, Barcenas CH, Ehlers II RA, Bedrosian I, Cormier J, Susan E. Optimizing Survivorship for Breast Cancer Patients: Creating Standardized Metrics for the Diagnosis of Breast Cancer-Related Lymphedema, 2016. e-Pub 2016.
57. Fayanju O, Hall C, Karhade M, Kuerer HM, Valad LM, Lucci A, Bauldry JB, DeSnyder SM, Barcenas CH. Body Mass Index Mediates the Prognostic Significance of Circulating Tumor Cells in Inflammatory Breast Cancer. American Society if Breast Surgeons 17th Annual Meeting, Dallas, TX. American Journal of Surgery, 2016. e-Pub 2016.
58. DeSnyder SM. Eliminating Axillary Surgery in Exceptional Responders to Neoadjuvant Chemotherapy (NCT) with documented Pathologic Complete Response in the Breast, 2016. e-Pub 2016.
59. Yi M, Mittendorf EM, Black S, Kuerer HM, Bedrosian I, Babiera G, Caudle AS, DeSnyder SM, Hunt KK. Accuracy of Sentinel Lymph Node Dissection (SLND) in Patient with Multicentric Breast Cancer. Ann Surg Oncol 23(S65-S66), 2016. e-Pub 2016.
60. Hall C, Valad L, Karhade M, Kuerer HK, DeSnyder SM, Lucci A. Circulating Tumor Cells after Neoadjuvant Therapy in Stage I-III Triple-Negative Breast Cancer 25(9):122, 2015. e-Pub 2015.
61. Hall CS, Karhade M, Laubacher BA, Kuerer HM, Krishnamurthy S, DeSnyder SM, Anderson AE, Valero V, Ueno NT, Li Y, Su X, Lucci A. Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer. National Cancer Institute 107(11), 2015. e-Pub 2015.
62. Valero V, Tripathy D, DeSnyder SM, Lucci A, Woodward W, Reuben JM, Arun BK, Murray III JL, Booser DJ, PArker CA, Lim B, Wang X, Willet JS, Krishnamurthy S, Brewster A, Babiera G, Alvarez R, Marx A. Phase II Study of Panitumumam, Nab-Paclitaxel and Carboplatin Followed by FEC Neoadjuvant Chemotherapy for Patients with Primary Inflammatory Breast Cancer (HR+ or TNBC). Presented at the American Society of Clinical Oncology 33 (#1065), 2015. e-Pub 2015.
63. Hall C, Karhade M, Laubacher B, Anderson, Kuerer HM, DeSnyder SM, Lucci A. Circulating Tumor Cells after Neoadjuvant Therapy in Stage I-III Triple-Negative Breast Cancer. Society of Surgical Oncology 66th Annual Cancer Symposium 22(SS3):552-558, 2015. e-Pub 2015.
64. DeSnyder SM, Hall C, Karhade M, Kuerer K, Lucci A. Presence of Circulating Tumor Cells and Disseminated Tumor Cells Does Not Predict Site of Recurrent or Metastatic Disease. Presented at the Society of Surgical Oncology 66th Annual Cancer Symposium. Annals of Surgical Oncology 22:S72, 2015. e-Pub 2015.
65. Black DM, Wagner J, Mittendorf EA, Hwang RF, DeSnyder SM, Ames F, Yoburn T, Wipf N, Gollihar S, Meric-Bernstam F, Dogan BE, Dryden M, Yang WT, Rohren E, Gilcrease M, Kuerer HM, Hunt KK, Caudle AS. Implementing a Radioactive Seed Localization Program in Breast Cancer Surgery: A Multidisciplinary Approach. Ann Surg Oncol 22(S64), 2015. e-Pub 2015.
66. Kalambo MJ, Dogan BE, Santiago L, DeSnyder SM, Gilcrease M, Whitman GJ. Step-by-Step: Planning a Needle Localization Procedure. Presented at the Radiological Society of North America Meeting, 2014. e-Pub 2014.
67. Masuda H, Chavez-MacGregor M, Liu DD, Alvarez RH, Krishnamurthy S, Lucci A, Woodward W, Gildy B, Mittendorf EA, DeSnyder SM, Shen Y, Willey JS, Hortobagyi GN, Valero V, Ueno NT. Predictors of Poor Clinical Outcome Among Patients with Inflammatory Breast Cancer (IBC) Who Did and Did Not Achieve Pathological Complete Response (pCR) After Neoadjuvant Systemic Chemotherapy. Presented at the 36th Annual CTRC AACR San Antonio Breast Cancer Symposium. Cancer Research 73(24 Suppl), 2013. e-Pub 2013.
68. FitzSullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HM. Incidence and Consequence of Close Margins in Patients with Ductal Carcinoma in Situ Treated with Mastectomy: Is Further Therapy Warranted? Presented at the Society of Surgical Oncology 66th Annual Cancer Symposium. Annals of Surgical Oncology 20(13):4103-4112, 2013. e-Pub 2013.
69. FitzSullivan E, Ross MI, Meric-Bernstam F, DeSnyder SM, Bedrosian I, Black S, Lucci A, Caudle AS, Babiera GV, Mittendorf EA, Hunt KK, Yi M, Kuerer HM, Bassett TL, Hwang RF. Outcomes of Sentinel Lymph Node Positive Breast Cancer Patients Treated with Mastectomy without Treatment of the Axilla: An Institutional and SEER Based Analysis. Presented at Breast Cancer Symposium 2013, American Society of Clinical Oncology. Journal of Clinical Oncology 31(Suppl 26), 2013. e-Pub 2013.
70. Gainer SM, Krishnamurthy S, Bhattacharya A, Lodhi A, Hall C, Bedrosian I, Kuerer HM, Lucci A. Use of Disseminated Tumor Cells to Predict Outcome in Patients with Stage I-III Breast Cancer. Presented at Breast Cancer Symposium 2012, American Society of Clinical Oncology, 2012. e-Pub 2012.
71. MacDermed D, Houtman K, Thang S, Gainer SM, Caudle A, Strom E, Woodward W, Buchholz T, Hoffman K. Radiation to the Whole Breast in the Prone Position: Retropective Analysis of Axillary Dose. Presented at Breast Cancer Coordinated Care (BC3), 2012. e-Pub 2012.
72. Gainer SM, Krishnamurthy S, Bhattacharyya A, Lodhi A, Hall CS, Bedrosian I, Kuerer HM, Lucci A. Single Center Experience with Disseminated Tumor Cells as Predictors of Outcome in Patients with Stage I-III Breast Cancer. Presented at the Society of Surgical Oncology 65th Annual Cancer Symposium(P57), 2012. e-Pub 2012.
73. Gainer SM, Lodhi AK, Bhattacharyya A, Hall CS, Krishnamurthy S, Kuerer HM, Lucci A. Invasive Lobular Carcinoma Predicts Micrometastatic Disease in Stage I-III Breast Cancer. Presented at the 7th Annual Academic Surgical Congress 172(2):227, 2012. e-Pub 2012.
74. Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns. Presented at the 13th Annual Meeting of The American Society of Breast Surgeons 19(10):3144-3151, 2012. e-Pub 2012.
75. Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. Changing Behavior in Clinical Practice in Response to the ACOSOG Z0011 Trial: A Survey of the American Society of Breast Surgeons. Presented at the 13th Annual Meeting of The American Society of Breast Surgeons 19(10):3152-3158, 2012. e-Pub 2012.
76. Gainer SM, Krishnamurthy S, Bhattacharyya A, Lodhi A, Hall C, Kuerer H, Bedrosian I, Anderson A, Singh B, Lucci A. Nomogram Incorporating SLN Metastasis Size Provides the Most Accurate Prediction of Non-SLN Involvement in Breast Cancer Patients. Presented at the 34th Annual CTRC AACR San Antonio Breast Cancer Symposium(P3-07-11), 2011. e-Pub 2011.
77. Gainer SM, Krishnamurthy S, Bhattacharyya A, Lodhi A, Hall C, Kuerer H, Bedrosian I, Anderson A, Singh B, Lucci A. Circulating Tumor Cells after Neoadjuvant Therapy Predict Outcome in Stage I-III Breast Cancer Presented at the 34th Annual CTRC AACR San Antonio Breast Cancer Symposium((P3-4-07-11)), 2011. e-Pub 2011.
78. Gainer SM, Lodhi AK, Krishnamurthy S, Jackson S, Hall CS, Andreopoulou E, Singh B, Bedrosian I, Meric-Bernstam F, Kuerer HM, Hunt KK, Cristofanilli M, Lucci A. Predictors of Persistent Micrometastatic Disease after Neoadjuvant Chemotherapy. Presented at the 32nd Annual CTRC AACR San Antonio Breast Cancer Symposium. Cancer Res 69(24 Suppl), 2009. e-Pub 2009.
79. Rebello E, Black S, DeSnyder SM, Cleckler-Hughes K, Engle R, Cohen L. Hypnosedation as an Alternative to General Anesthesia for Breast Cancer Surgery in a Patient with Severe Chronic Obstructive Pulmonary Disease. Evidence Based Perioperative Medicine Conference.

Book Chapters

1. DeSnyder SM, McLaughlin SA. Lymphedema – Pathophysiology, Prevention, and Treatment. In: In: Fischer’s Mastery of Surgery, 509-521, 2023.
2. Sun S, DeSnyder SM. The Surgical Management of Locally Advanced and Stage IV Breast Cancer. In: Spear's Surgery of the Breast: Principles and Art. 4th. Wolters Kluwer Health, 105-114, 2021.
3. Murphy, BL, Hunt, KK, DeSnyder, SM. The multidisciplinary approach to breast cancer management, 137-156, 2021.
4. Murphy B, Hunt KK, DeSnyder SM. The Multidisciplinary Approach in Breast Cancer Management. In: Breast Cancer Screening and Diagnosis. Role of Imaging and Management, 137-156, 2021.
5. Lucci, A, DeSnyder SM, Fayanju L. Sentinel Lymph Node Biopsy in Breast Cancer. In: Fischer’s Mastery of Surgery, 7th edition. 7th, 668-671, 2019.
6. DeSnyder, SM, Shaitelman S, Schaverien MV. Lymphedema and Body Image. In: Principles and Practices of Body Image Care for Cancer Patients, 213-230, 2018.
7. Hunt KK, DeSnyder SM. The Multidisciplinary Approach in Breast Cancer Management. In: Breast Cancer Screening and Diagnosis. Springer Science + Business Media, 393-409, 2015.
8. DeSnyder SM. Neoadjuvant/Adjuvant Therapy for Breast Cancer. In: Complex General Surgical Oncology: A Case-Based Approach. Future Medicine, 43-53, 2013.
9. DeSnyder SM. Nonductal Malignancies. In: Complex General Surgical Oncology: A Case-Based Approach. Future Medicine, 55-62, 2013.
10. DeSnyder SM. Regional Lymph Node Metastases in Breast Cancer. In: Complex General Surgical Oncology: A Case-Based Approach. Future Medicine, 33-41, 2013.
11. Gainer SM, Yamauchi H, Lucci A. Surgical Therapy for Inflammatory Breast Cancer. In: Inflammatory Breast Cancer: An Update. 1st. Springer, 67-73, 2012.
12. Gainer SM, Lodhi AK, Lucci A. Breast Cancer Occult Micrometastasis in Bone Marrow and Blood. In: Advanced Therapy for Breast Disease. 3rd. People's Medical Publishing House-USA, 951-956, 2012.